FAST-ACTING INSULIN ASPART AT HIGH DOSES IN INDIVIDUALS WITH TYPE 2 DIABETES

被引：0
|
作者：
Bowering, K. [1 ]
Harvey, J. [2 ]
Kolaczynski, J. [3 ]
Snyder, J. [4 ]
Bode, B. [5 ]
机构：
[1] Univ Alberta, Div Endocrinol & Metab, Edmonton, AB, Canada
[2] Bangor Univ, Wrexham Acad Unit, Bangor, Gwynedd, Wales
[3] Novo Nordisk Inc, Clin Dev Diabet & Obes, Plainsboro, NJ USA
[4] Novo Nordisk Inc, Clin Dev Med & Regulatory Affairs, Plainsboro, NJ USA
[5] Atlanta Diabet Associates, Atlanta, GA USA
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
303
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [21] The Impact of Baseline BMI and HbA1c on Glycemic Control after Treatment with Fast-Acting Insulin Aspart in Individuals with Type 2 Diabetes
    Bowering, Keith
    Bode, Bruce W.
    Harris, Stewart B.
    Piletic, Milivoj
    Babu, Vinay
    Dethlefsen, Claus
    Rodbard, Helena W.
    DIABETES, 2017, 66 : A253 - A253
  • [22] CLINICAL USE OF FAST-ACTING INSULIN ASPART IN PEOPLE WITH TYPE 1 AND TYPE 2 DIABETES, A SURVEY OF PHYSICIANS' EXPERIENCES AND TREATMENT SATISFACTION
    Baru, A.
    Fernandes, J.
    Amir, S.
    Ekelund, M.
    VALUE IN HEALTH, 2019, 22 : S159 - S160
  • [23] A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes
    Beck, Roy W.
    Russell, Steven J.
    Damiano, Edward R.
    El-Khatib, Firas H.
    Ruedy, Katrina J.
    Balliro, Courtney
    Li, Zoey
    Calhoun, Peter
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (10) : 681 - 696
  • [24] The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes
    Biester, Torben
    von Dem Berge, Thekla
    Bendtsen, Line Quist
    Bendtsen, Mette Dahl
    Rathor, Naveen
    Danne, Thomas
    Haahr, Hanne
    PEDIATRIC DIABETES, 2020, 21 (05) : 781 - 790
  • [25] Efficacy and safety of fast-acting insulin aspart versus insulin aspart both in combination with insulin degludec with or without metformin in adults with diabetes
    Du, J.
    Wang, G. X.
    Wang, G.
    Liu, M.
    Thamattoor, U. K.
    Luan, Z. J.
    Alibegovic, A. C.
    Mu, Y. M.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S377 - S377
  • [26] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Haahr, Hanne
    Pieber, Thomas R.
    Mathieu, Chantal
    Gondolf, Theis
    Shiramoto, Masanari
    Erichsen, Lars
    Heise, Tim
    CLINICAL PHARMACOKINETICS, 2019, 58 (05) : 639 - 649
  • [27] Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
    Hanne Haahr
    Thomas R. Pieber
    Chantal Mathieu
    Theis Gondolf
    Masanari Shiramoto
    Lars Erichsen
    Tim Heise
    Clinical Pharmacokinetics, 2019, 58 : 639 - 649
  • [28] Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
    Bode, Bruce W.
    Iotova, Violeta
    Kovarenko, Margarita
    Laffel, Lori M.
    Rao, Paturi V.
    Deenadayalan, Srikanth
    Ekelund, Magnus
    Larsen, Steffen Falgreen
    Danne, Thomas
    DIABETES CARE, 2019, 42 (07) : 1255 - 1262
  • [29] Use of fast-acting insulin aspart in insulin pump therapy in clinical practice
    Evans, Mark
    Ceriello, Antonio
    Danne, Thomas
    De Block, Christophe
    DeVries, J. Hans
    Lind, Marcus
    Mathieu, Chantal
    Norgaard, Kirsten
    Renard, Eric
    Wilmot, Emma G.
    DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2039 - 2047
  • [30] Projected long-term outcomes in patients with type 1 diabetes treated with fast-acting insulin aspart vs conventional insulin aspart in the UK setting
    Russell-Jones, David
    Heller, Simon R.
    Buchs, Sarah
    Sandberg, Anna
    Valentine, William J.
    Hunt, Barnaby
    DIABETES OBESITY & METABOLISM, 2017, 19 (12): : 1773 - 1780
12345